By Locust Walk
To listen to an audio podcast, mouse over the title and click Play. Open iTunes to download and subscribe to podcasts.
Biotalk is a deal maker’s playbook to making an impact and generating returns in life sciences. Our guest speakers are industry leaders and institutional and family office investors who share their experience and views on deal making and industry trends to educate and inform.
||CleanBiotalk Episode 5, Fred Chereau, LogicBio||In this episode of Biotalk, Josh Hamermesh, VP of Locust Walk interviewed his long lasting friend and colleague, Fred Chereau, CEO of LogicBio. They discussed industry trends on gene therapy and LogicBio recent||10/16/2017||Free||View in iTunes|
||CleanEpisode 4: Stuart Kliman, Vantage Partners||In this Episode of Biotalk, Locust Walk’s Vice President, Josh Hamermesh, spoke to Stuart Kliman (email@example.com), Founder and Partner at Vantage Partners, a global management consulting firm that specializes in the areas of negotiation..||7/13/2017||Free||View in iTunes|
||CleanEpisode 3: Roger Longman, Real Endpoints||In this episode of BioTalk, Locust Walk’s Vice President, Josh Hamermesh, spoke to Roger Longman, CEO of Real Endpoints, about the pricing and reimbursement issues that are affecting the biopharmaceutical industry, with a particular focus on the...||4/18/2017||Free||View in iTunes|
||CleanEpisode 2: Bradley Campbell, Amicus Therapeutics||In this episode of Biotalk podcast, Josh Hamermesh, Vice President of Locust Walk interviews Bradley Campbell, President& COO of Amicus Therapeutics. Amicus is very much at the forefront developing and commercializing important therapies to...||3/23/2017||Free||View in iTunes|
||CleanEpisode 1: Chris Ehrlich, Locust Walk||Locust Walk||2/6/2017||Free||View in iTunes|